Resveratrol: Benefits, Dosage & What the Science Says
Resveratrol is a stilbene polyphenol found in red grape skins, berries, and — most concentrated for supplement use — the root of Japanese knotweed (Polygonum cuspidatum, known in TCM as Hǔ Zhàng / 虎杖). It gained scientific prominence as a proposed explanation for the 'French Paradox' and as a direct activator of SIRT1, the sirtuin deacetylase central to the biology of caloric restriction and longevity. The science is more nuanced than early enthusiasm suggested — human evidence remains emerging — but the mechanistic case for resveratrol in combination with NAD+ precursors (NMN, NR) is coherent, and cardiovascular and anti-inflammatory evidence in human trials is promising.
What Is Resveratrol?
Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic compound produced by plants as a phytoalexin — a stress-response chemical synthesized in reaction to UV radiation, fungal infection, and physical injury. It occurs in two stereoisomers: trans-resveratrol (the biologically active form) and cis-resveratrol (inactive). Commercial supplement sources are almost exclusively Japanese knotweed root (Polygonum cuspidatum / Reynoutria japonica), which contains up to 0.5% trans-resveratrol by dry weight — far higher than red wine (~1–2 mg/L) or grape skin (~50–100 μg/g). Obtaining supplemental doses from red wine would require consumption of multiple bottles daily — a dose-delivery method not recommended by anyone.
Resveratrol's entry into longevity science came through David Sinclair's landmark 2003 paper in Nature demonstrating that resveratrol directly activates SIRT1 — a NAD+-dependent deacetylase that regulates gene expression in response to caloric restriction signals. In animal models, resveratrol activation of SIRT1 mimicked multiple effects of caloric restriction: improved insulin sensitivity, mitochondrial biogenesis, reduced fat accumulation, and extended lifespan in simple organisms. In obese mice fed high-fat diets, resveratrol significantly improved metabolic parameters and extended median lifespan. These findings generated enormous scientific and popular interest and remain influential in longevity biology, though subsequent mechanistic debates about whether SIRT1 activation is direct or indirect have complicated the narrative.
The primary challenge with resveratrol as a supplement is bioavailability. Trans-resveratrol is absorbed readily from the GI tract but undergoes extensive first-pass metabolism — rapid glucuronidation and sulfation in the gut wall and liver — resulting in peak plasma concentrations that are modest relative to doses required for in vitro sirtuin activation. Micronized resveratrol has improved bioavailability over standard crystalline forms; liposomal encapsulation and NXT-Gen formulations (e.g., Longevinex) may improve bioavailability further. Taking resveratrol with fat-containing foods or alongside quercetin (which inhibits glucuronidation enzymes) may improve bioavailability. This is an active area of formulation research, not a settled problem.
In TCM, Hǔ Zhàng (虎杖 — Japanese knotweed / Polygonum cuspidatum) is used to move blood, clear heat, resolve dampness, and relieve pain — classical indications for inflammatory and circulatory conditions. The biological activity of resveratrol extracted from this plant partially explains these traditional applications through modern pharmacology.
Evidence-Based Benefits
SIRT1 Activation and Longevity Pathway Support
Resveratrol's most discussed mechanism is direct or indirect activation of SIRT1 — the NAD+-dependent deacetylase that functions as a master regulator of metabolic adaptation to caloric restriction. SIRT1 activation has downstream effects on PGC-1α (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and NF-κB (inflammation suppression). The most compelling human evidence comes from a landmark study by Timmers et al. (2011) published in Cell Metabolism: 11 obese men supplemented with resveratrol 150 mg/day for 30 days showed metabolic changes mimicking caloric restriction — reduced fasting glucose, insulin, triglycerides, and resting metabolic rate — with muscle biopsy-confirmed increases in SIRT1 and AMPK activity. This is direct human tissue evidence of the proposed mechanism, not just pharmacokinetics. The synergy with NMN/NR is logical: resveratrol activates SIRT1; NMN supplies the NAD+ that SIRT1 requires as a substrate — the combination is greater than either alone in animal models and is the basis for the Sinclair lab's recommended protocol.
Cardiovascular Protection and Endothelial Function
Resveratrol's cardiovascular effects include upregulation of eNOS (endothelial nitric oxide synthase) — increasing nitric oxide production and vasodilation — inhibition of platelet aggregation, reduction of LDL oxidation, and anti-inflammatory effects on vascular endothelium. A meta-analysis of 21 randomized controlled trials found that resveratrol supplementation significantly reduced LDL cholesterol, triglycerides, and blood pressure compared to placebo, with the most consistent effects at doses of 150–500 mg/day. A separate meta-analysis specifically examining arterial stiffness (pulse wave velocity) found significant improvements with resveratrol supplementation. These cardiovascular effects are consistent with resveratrol's proposed mechanism: nitric oxide-mediated vasodilation, LDL antioxidant protection, and reduction of endothelial inflammation. For adults with cardiovascular risk factors, resveratrol's lipid, vascular, and anti-inflammatory effects represent a coherent, if emerging, clinical rationale.
Anti-Inflammatory and Antioxidant Activity
Resveratrol inhibits NF-κB, COX-1 and COX-2, and multiple pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) through multiple upstream mechanisms — SIRT1-mediated NF-κB deacetylation and direct COX enzyme inhibition. As an antioxidant, it scavenges free radicals and upregulates endogenous antioxidant enzymes (catalase, SOD, GPx) through Nrf2 activation. A randomized crossover trial in healthy individuals found that resveratrol supplementation (250 mg/day) significantly reduced inflammatory markers including hs-CRP and IL-6 over 6 weeks. In metabolically compromised populations (obesity, type 2 diabetes), anti-inflammatory effects are more pronounced, consistent with the concept that resveratrol is most beneficial in the context of oxidative stress and inflammatory burden — which increases with aging. Combined with its SIRT1 and cardiovascular mechanisms, the anti-inflammatory action represents a third independent reason for considering resveratrol in a longevity-focused supplement regimen.
Recommended Dosage
| Form | Typical Dose | Timing | Notes |
|---|---|---|---|
| Micronized trans-resveratrol capsule | 150–500 mg daily | With the largest fat-containing meal of the day; morning preferred for NMN combination | Micronized form has improved bioavailability over standard crystalline resveratrol; 150 mg/day is the dose used in the Timmers Cell Metabolism trial; higher doses show diminishing incremental absorption |
| Liposomal resveratrol | 100–250 mg daily | With or without food (lipid delivery system compensates for missing fat) | Significantly improved bioavailability; allows lower nominal dose with comparable plasma levels; more expensive per mg; emerging evidence base |
| Trans-resveratrol + NMN combination | 150–500 mg resveratrol + 250–500 mg NMN daily | Morning with a fat-containing meal (fat critical for resveratrol) | Sinclair lab recommended protocol — resveratrol activates SIRT1; NMN provides NAD+ substrate; complementary mechanisms; both individually well-tolerated |
| Trans-resveratrol + quercetin combination | 200–400 mg resveratrol + 250–500 mg quercetin | With a fat-containing meal | Quercetin inhibits glucuronidation enzymes that metabolize resveratrol, potentially raising plasma levels; both are polyphenols with complementary anti-inflammatory mechanisms |
150–500 mg/day of trans-resveratrol. Take with a fat-containing meal. Micronized or liposomal forms preferred for bioavailability. Morning dosing aligns with NMN combination protocols.
Safety, Side Effects & Interactions
How to Choose a Quality Resveratrol
Trans-resveratrol is the only biologically active stereoisomer — products should specify trans-resveratrol, not just 'resveratrol.' Japanese knotweed root extract (Polygonum cuspidatum) is the standard supplement source, far more concentrated than grape skin or red wine. Look for products standardizing to ≥98% trans-resveratrol by HPLC analysis.
Bioavailability formulation is the most meaningful quality variable. Standard crystalline resveratrol has acceptable but relatively low bioavailability due to rapid phase II metabolism. Micronized resveratrol (reduced particle size) improves dissolution and absorption without additional processing. Liposomal formulations offer the highest bioavailability per milligram. Taking any resveratrol form with a fat-containing meal (10+ grams of fat) significantly improves absorption — this single habit may matter more than paying premium for formulation differences. Quercetin co-ingestion is theoretically bioavailability-enhancing by CYP inhibition and is available in many combination products.
Dose: more is not better beyond a threshold. Resveratrol absorption does not scale linearly with dose — a 500 mg dose does not produce proportionally higher plasma levels than 150 mg due to saturable absorption mechanisms. The Timmers human trial showing metabolic changes mimicking caloric restriction used 150 mg/day — which suggests physiological effects at a dose well within the typical supplement range. Third-party testing for heavy metals and purity (confirming trans vs cis content) is advisable for a compound where source and manufacturing quality significantly affect active compound content.
Looking for a quality source? We recommend products that meet third-party testing standards.
Affiliate disclosure: We may earn a commission on qualifying purchases at no extra cost to you.
Works Well With
Research suggests Resveratrol may complement:
Traditional Use
Frequently Asked Questions
Does resveratrol really activate longevity pathways?
The mechanistic case is credible, with important nuance. Resveratrol activates SIRT1, the NAD+-dependent deacetylase central to caloric restriction biology — though the mechanism is debated (direct allosteric activation vs. indirect via AMPK). The Timmers Cell Metabolism trial demonstrated human tissue-level SIRT1 and AMPK activation with 150 mg/day in obese men, alongside metabolic improvements mimicking caloric restriction. This is not proof of extended human lifespan — that evidence does not exist for any supplement. It is evidence of engaging longevity pathways in human tissue at achievable doses. Resveratrol alone is unlikely to be transformative; as part of a regimen also including NAD+ precursors and lifestyle interventions, the mechanistic rationale is among the strongest of any polyphenol supplement.
What is the connection between resveratrol and the French Paradox?
The French Paradox — the observation that French populations have low rates of cardiovascular disease despite high saturated fat consumption — was proposed in the early 1990s to be partially explained by high red wine consumption. Resveratrol in red wine was suggested as a protective factor. Subsequent research complicated this narrative: red wine resveratrol concentrations (1–2 mg/L) are far too low to achieve the plasma levels associated with measurable effects in supplementation studies. The amounts of resveratrol found in typical wine consumption are probably insufficient to account for the cardiovascular protection attributed to moderate wine drinking — other components (alcohol itself at moderate doses, flavonoids, procyanidins) are more plausible contributors. Resveratrol's therapeutic potential requires supplemental doses, not wine. The French Paradox origin story is historically interesting but should not drive dose or source decisions.
How much resveratrol is in red wine?
Red wine contains approximately 1–2 mg of resveratrol per liter — so a standard 150 mL glass contains roughly 0.15–0.3 mg. Clinical trials demonstrating measurable biological effects use 150–500 mg/day — meaning you would need to drink 500–3,000 glasses of wine daily to replicate supplemental doses from wine. This is not recommended for health, safety, or practical reasons. Supplements derived from Japanese knotweed root, which contains up to 50–100 mg of trans-resveratrol per gram of standardized extract, are the only practical delivery vehicle for therapeutic resveratrol. This context is useful for correctly calibrating the relationship between wine consumption and resveratrol biology.
Should I take resveratrol with NMN or separately?
Taking them together in the morning with a fat-containing meal is the Sinclair lab protocol and mechanistically sensible. The rationale: SIRT1 activated by resveratrol requires NAD+ as a co-substrate to perform deacetylation reactions. NMN raises NAD+ levels, providing the substrate SIRT1 needs to act on when activated by resveratrol. This is a complementary mechanism, not a redundant one — they are not doing the same thing. Practically, taking both in the morning with fat ensures resveratrol absorption (fat-dependent) and aligns with NAD+ synthesis circadian rhythm. There is no strong evidence that separating the two improves outcomes, and the convenience of a combined morning dose is practical for adherence.
Is resveratrol safe for people with hormone-sensitive conditions?
This requires physician consultation before use. Resveratrol has weak phytoestrogenic activity — it binds estrogen receptors at high concentrations. In cell culture models, resveratrol can either stimulate or inhibit estrogen receptor signaling depending on the concentration and tissue context, making its net estrogenic effect unpredictable. At typical supplemental doses (150–500 mg/day), clinically significant estrogenic effects have not been identified in human trials. However, individuals with estrogen-receptor positive breast cancer, endometriosis, uterine fibroids, or other hormone-sensitive conditions should not use resveratrol without explicit approval from their oncologist or specialist. The precautionary principle applies here — the theoretical risk is real, even if the clinical magnitude at supplemental doses is uncertain.
How long does resveratrol take to work?
The Timmers trial found measurable metabolic changes (reduced glucose, insulin, triglycerides, resting metabolic rate) and muscle biopsy-confirmed SIRT1 activation after 30 days of 150 mg/day in obese men — suggesting relatively rapid engagement of the proposed mechanisms. For cardiovascular effects (lipid changes, arterial stiffness), most trials run 4–12 weeks and find measurable changes within that window. Anti-inflammatory markers improve within 4–8 weeks in responsive individuals. Subjective effects — energy, wellbeing — are variable and not a reliable endpoint. As with most supplements targeting aging biology, effects are gradual improvements in underlying physiology rather than acute, perceivable changes. Consistent daily use for 3+ months, combined with lifestyle practices that support the same pathways, is the framework for realistic expectation.
References
- Timmers S et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612–622. — PMID:22055504
- Tabrizi R et al. The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60(3):375–390. — PMID:30816367
- Movahed A et al. Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid Based Complement Alternat Med. 2013;2013:851267. — PMID:23316621
- Howitz KT et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196. — PMID:12939617
Last reviewed: April 21, 2026. For informational purposes only. See full disclaimer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
AI & Developer Endpoint
/data/supplements/resveratrol.json
This supplement profile ships machine-readable JSON-LD and a structured data endpoint for AI systems and developers.